All In Biotech

Free tool

FAERS Monitor: Trikafta (Copackaged)

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 217660 or its brand name (Trikafta (Copackaged), Elexacaftor, Ivacaftor, Tezacaftor, Ivacaftor). Reports on generic versions are filed under their own applications.

Reports

12,580

Serious

5,317

42% of reports

Hospitalization

3,485

Death reported

247

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • infective pulmonary exacerbation of cystic fibrosis823
  • headache776
  • anxiety635
  • cough602
  • rash573
  • fatigue546
  • productive cough545
  • weight increased521
  • cystic fibrosis513
  • abdominal pain upper480
  • depression461
  • hospitalisation443
  • pneumonia399
  • diarrhoea389
  • mental disorder357

Reports by year received

View as table
YearReports
20181
2019500
20205,170
20211,161
20221,050
20231,297
20241,438
20251,259
2026704

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,041,579 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
infective pulmonary exacerbation of cystic fibrosisSignal823297.6276.9206,357
cystic fibrosisSignal513170.6156.178,365
productive coughSignal54519.317.89,351
mental disorderSignal35713.812.54,207
hospitalisationSignal4434.84.41,348
abdominal pain upperSignal4803.93.61,042
weight increasedSignal5213.93.61,128
anxietySignal6353.73.51,285
coughSignal6023.63.31,138
depressionSignal4613.43.1782
rashSignal5732.22.0381
headacheSignal7762.11.9441
pneumoniaSignal3992.11.9220
fatigue5461.21.114
diarrhoea3891.00.90

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.